These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17393008)

  • 1. Availability of new therapy increases interest in lowering heart rate to improve cardiovascular disease outcomes.
    Cardiovasc J S Afr; 2007; 18(1):63-4. PubMed ID: 17393008
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical management of patients with angina. Has first-line management changed?
    Chatterjee K; Rouleau JL; Parmley WW
    JAMA; 1984 Sep; 252(9):1170-6. PubMed ID: 6147425
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology of calcium antagonists].
    Klaus W
    Fortschr Med; 1984 Jul; 102(27-28):728-31. PubMed ID: 6479816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of reduction in heart rate in cardiovascular disease.
    Hjalmarson A
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II3-7. PubMed ID: 9853192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic receptors: new concepts and implications for cardiovascular therapeutics.
    Colucci WS; Braunwald E
    Cardiovasc Clin; 1984; 14(3):39-59. PubMed ID: 6144390
    [No Abstract]   [Full Text] [Related]  

  • 6. Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure).
    Nikolaidis LA; Trumble D; Hentosz T; Doverspike A; Huerbin R; Mathier MA; Shen YT; Shannon RP
    Eur J Heart Fail; 2004 Jun; 6(4):409-19. PubMed ID: 15182765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the relationship between beta-blocker-induced heart rate lowering and cardiovascular outcomes the result of confounding by indication?
    Phillips RA
    J Am Coll Cardiol; 2009 Jun; 53(22):2101; author reply 2106-7. PubMed ID: 19477364
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated heart rate in cardiovascular diseases: a target for treatment?
    Palatini P
    Prog Cardiovasc Dis; 2009; 52(1):46-60. PubMed ID: 19615493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-receptor blockers in ischemic heart disease: the pathophysiological and clinical aspects].
    Urbaszek W; Modersohn D
    Z Arztl Fortbild (Jena); 1979 Feb; 73(3):101-6. PubMed ID: 34938
    [No Abstract]   [Full Text] [Related]  

  • 10. Ask the doctor. Do beta blockers and ACE inhibitors help or harm the heart?
    Lee T
    Harv Heart Lett; 2007 Aug; 17(12):8. PubMed ID: 17722253
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood pressure lowering efficacy of beta-blockers added to monotherapy with a thiazid or a calcium antagonist--a survey of a Cochrane review].
    Ibsen H; Svendsen TL
    Ugeskr Laeger; 2011 Aug; 173(35):2107-9. PubMed ID: 21884659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grapefruit-drug interactions.
    Straughan JL
    Cardiovasc J S Afr; 2007; 18(1):39-40. PubMed ID: 17392996
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of beta-blocking drugs in angina pectoris: a review.
    Robinson BF
    Postgrad Med J; 1976; 52 Suppl 4():43-5. PubMed ID: 9630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel-antagonists and the cardiovascular system.
    Carmeliet E
    Acta Cardiol; 1986; 41(2):133-46. PubMed ID: 2424201
    [No Abstract]   [Full Text] [Related]  

  • 16. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonism: a new approach.
    Nayler WG
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():3-13. PubMed ID: 6288293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of combination therapy for achieving goal blood pressure in high CV risk patients.
    Cardiovasc J S Afr; 2001; 12(1):54-5. PubMed ID: 11474688
    [No Abstract]   [Full Text] [Related]  

  • 19. [Selective action of calcium antagonists].
    Heinzl S
    Med Monatsschr Pharm; 1990 Mar; 13(3):66-8. PubMed ID: 2319983
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic effects of anesthetic induction in patients treated with beta and calcium channel blockers.
    Samad K; Khan F; Azam I
    Middle East J Anaesthesiol; 2008 Jun; 19(5):1111-28. PubMed ID: 18637611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.